Two is better than one; toward a rational design of combinatorial therapy
Author:
Funder
Novartis
Publisher
Elsevier BV
Subject
Molecular Biology,Structural Biology
Reference43 articles.
1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011
2. Synthetic lethality and cancer therapy: lessons learned from the development of PARP inhibitors;Lord;Annu Rev Med,2015
3. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer;Brechbiel;Cancer Treat Rev,2014
4. mTORC1-driven tumor cells are highly sensitive to therapeutic targeting by antagonists of oxidative stress;Li;Cancer Res,2016
5. Combined inhibition of MEK and mTOR has a synergic effect on angiosarcoma tumorgrafts;Andersen;Int J Oncol,2015
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting multiple hallmarks of mammalian aging with combinations of interventions;Aging;2024-08-18
2. Construction of a Waddington-like landscape model that can guide clinical exploration of p53-dynamics-activating parameters in the face of divergent p53 dynamics;Communications in Nonlinear Science and Numerical Simulation;2024-05
3. Identification of a novel DNA repair inhibitor using an in silico driven approach shows effective combinatorial activity with genotoxic agents against multidrug‐resistant Escherichia coli;Protein Science;2024-03-19
4. Pulsed stimuli entrain p53 to synchronize single cells and modulate cell-fate determination;2023-10-27
5. Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient‐derived orthotopic xenografts, cell lines and tumor entities;Molecular Oncology;2023-10-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3